DA-75-KD59_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, (2S,3R)-N1-((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4-hydroxy-3-(hydroxymethyl)-2-p-tolylsuccinamide, MMP-13 (Collagenase 3) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-1 (Interstitial Collagenase) Inhibitors;ADAM17 (TNF-alpha-Converting Enzyme (TACE) Inhibitors);MMP-2 (Gelatinase A) Inhibitors targeting MMP1, MMP2, MMP9, MMP13, ADAM17 (Novartis, 9907830)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/9907830
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the DA-75-KD59_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
OXA1L oxidase (cytochrome c) assembly 1-like 0.870761
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.532624
PPDPF pancreatic progenitor cell differentiation and proliferation factor 0.456116
PGP phosphoglycolate phosphatase 0.436442
GNG5 guanine nucleotide binding protein (G protein), gamma 5 0.32273
CD59 CD59 molecule, complement regulatory protein 0.288044
DAD1 defender against cell death 1 0.228433
UQCRC1 ubiquinol-cytochrome c reductase core protein I 0.207901
ST3GAL3 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 0.203194

decreased expression

Symbol Name Standardized Value
SNN stannin -0.347161
PDLIM3 PDZ and LIM domain 3 -0.286023
EPS15 epidermal growth factor receptor pathway substrate 15 -0.262375
SLC25A44 solute carrier family 25, member 44 -0.233493
LARP4 La ribonucleoprotein domain family, member 4 -0.223517